AzTrials
AzTrials

MeditationMDMS3NCT02313779

Meditation and Decision Making Study III

A study testing Lovingkindness Meditation (LKM) and Mindfulness Meditation in people with Meditation, run by Barbara L. Fredrickson, PhD at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overarching goal of the proposed research is to investigate the role of emotions in facilitating successful lifestyle change, defined as healthy behavioral decisions repeated daily, or near daily. Read more about this study

Who is it for?
Ages 35 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Meditation
What is being tested?
Lovingkindness Meditation (LKM) and Mindfulness Meditation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
240 participants
Where
1 siteUnited States
Study dates
Dec 2014to Oct 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Fluent in written and spoken English, with a high school reading level
  • Willingness or interest in learning to meditate
  • Computer literate with internet access

Who cannot join

  • Individuals who are able to read Chinese logographs
  • Individuals who have or have had a regular meditation practice, defined as having attended a 6-week or longer meditation class, practicing meditation at least 3 days a week for up to 6-weeks.
  • Individuals with allergies to adhesive materials

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UNC PEP Lab

    Chapel Hill, North Carolina, 27514

Other trials in United States

About this study

Official title: Nonconscious Affective and Physiological Mediators of Behavioral Decision Making Study 3

The overarching goal of the proposed research is to investigate the role of emotions in facilitating successful lifestyle change, defined as healthy behavioral decisions repeated daily, or near daily.

Participants are asked to make two lab visits during the course of four weeks to complete electronic questionnaires, be monitored for psychophysiological activity (e.g. heart rate, blood pressure, respiration), and listen to a guided meditation audio track. Additionally, between the two visits participants will be asked to complete weekly surveys that ask about daily meditation practice (outside of the lab) and general emotions.

Conditions
Meditation
Being tested
Lovingkindness Meditation (LKM), Mindfulness Meditation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lovingkindness Meditation (LKM)Behavioural

    Compassionate behavior training (REVISE)

  • Mindfulness MeditationBehavioural

Study groups in NCT02313779
Study groupRoleWhat they receive
NeutralPlacebo comparatorReading passage about brain function which is masked as a news article.
Receives: Behavioral: Lovingkindness Meditation (LKM); Behavioral: Mindfulness Meditation
Lovingkindness Meditation (LKM)ExperimentalLovingkindness guided meditation experienced in the laboratory and 6 additional LKM meditations taken home on the iPod.
Receives: Behavioral: Lovingkindness Meditation (LKM)
Mindfulness MeditationPlacebo comparatorMindfulness guided meditation experienced in the laboratory and 6 additional Mindfulness meditations taken home on the iPod.
Receives: Behavioral: Mindfulness Meditation
PositivityExperimentalReading passage about prioritizing positive emotions which is masked as a news article.
Receives: Behavioral: Lovingkindness Meditation (LKM); Behavioral: Mindfulness Meditation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in positive emotions (as measured by the Modified Daily Emotions Scale)

    Modified Daily Emotions Scale (mDES) - This measure of explicit positive affect has been successfully used by the PI in multiple studies to detect changes in positive emotion. Previous work by the PI found that Cronbach's alpha coefficient for the mDES positive emotion composite variable was 0.93 in sample of mid-life community adults similar to those anticipated for this study.

    Measured: Baseline and Weeks 1, 2, and 3

  2. Change in nonconscious incentive salience (as measured by the Affect Misattribution Procedure)

    Affect Misattribution Procedure (AMP) - This measure of nonconscious incentive salience has acceptable internal consistency for an indirect measure of affect (.69 - .90) and has been found to predict judgments and behavioral outcomes above and beyond self-report measures.

    Measured: Baseline and Weeks 1, 2, and 3

  3. Changes in meditation time

    Self-reported meditation time recorded daily and weekly. In addition, meditation track play times will be recorded from the iPod.

    Measured: Weeks 1, 2, and 3

Secondary outcomes (1)
  1. Cardiac Vagal Tone

    This measure of parasympathetic control over the heart has been positively associated with both emotional and social functioning. Previous work by the PI's team has found that baseline vagal tone predicts increased positive response to lovingkindness meditation (LKM), and that LKM in turn increases vagal tone.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2014 (estimated)
  2. Study startDec 2014
  3. Primary completionOct 2015
  4. Study completionOct 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
240 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02313779
Sponsor's protocol ID
12-2428
Other IDs
R01AT007884-01
Acronym
MDMS3
Status last verified
Jul 2016
First submitted
8 Dec 2014
Last updated
15 Jul 2016
Results posted
No
Data monitoring committee
No

Publications

  • Fredrickson BL, Cohn MA, Coffey KA, Pek J, Finkel SM. Open hearts build lives: positive emotions, induced through loving-kindness meditation, build consequential personal resources. J Pers Soc Psychol. 2008 Nov;95(5):1045-1062. doi: 10.1037/a0013262.

    PubMed 18954193
  • Carmody J, Baer RA, L B Lykins E, Olendzki N. An empirical study of the mechanisms of mindfulness in a mindfulness-based stress reduction program. J Clin Psychol. 2009 Jun;65(6):613-26. doi: 10.1002/jclp.20579.

    PubMed 19267330
  • Johnson KJ, Waugh CE, Fredrickson BL. Smile to see the forest: Facially expressed positive emotions broaden cognition. Cogn Emot. 2010 Feb 19;24(2):299-321. doi: 10.1080/02699930903384667.

    PubMed 23275681
  • Payne BK, Cheng CM, Govorun O, Stewart BD. An inkblot for attitudes: affect misattribution as implicit measurement. J Pers Soc Psychol. 2005 Sep;89(3):277-93. doi: 10.1037/0022-3514.89.3.277.

    PubMed 16248714

Questions about this trial

What is this clinical trial studying?

A study testing Lovingkindness Meditation (LKM) and Mindfulness Meditation in people with Meditation, run by Barbara L. Fredrickson, PhD at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in positive emotions (as measured by the Modified Daily Emotions Scale) (time frame: Baseline and Weeks 1, 2, and 3). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02313779, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in